Annual EBIT
-$35.34 M
-$18.26 M-106.86%
December 31, 2023
Summary
- As of February 6, 2025, CADL annual earnings before interest & taxes is -$35.34 million, with the most recent change of -$18.26 million (-106.86%) on December 31, 2023.
- During the last 3 years, CADL annual EBIT has fallen by -$22.16 million (-168.04%).
- CADL annual EBIT is now -317.48% below its all-time high of -$8.47 million, reached on December 31, 2019.
Performance
CADL EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$10.16 M
+$11.51 M+53.12%
September 30, 2024
Summary
- As of February 6, 2025, CADL quarterly earnings before interest & taxes is -$10.16 million, with the most recent change of +$11.51 million (+53.12%) on September 30, 2024.
- Over the past year, CADL quarterly EBIT has increased by +$11.51 million (+53.12%).
- CADL quarterly EBIT is now -497.59% below its all-time high of -$1.70 million, reached on March 31, 2020.
Performance
CADL Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$49.83 M
-$2.39 M-5.05%
September 30, 2024
Summary
- As of February 6, 2025, CADL TTM earnings before interest & taxes is -$49.83 million, with the most recent change of -$2.39 million (-5.05%) on September 30, 2024.
- Over the past year, CADL TTM EBIT has dropped by -$2.39 million (-5.05%).
- CADL TTM EBIT is now -2830.94% below its all-time high of -$1.70 million, reached on March 31, 2020.
Performance
CADL TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
CADL EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -106.9% | +53.1% | -5.0% |
| 3 y3 years | -168.0% | -125.5% | -96.4% |
| 5 y5 years | -317.5% | -125.5% | -96.4% |
CADL EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -106.9% | at low | -173.5% | +53.1% | -102.8% | at low |
| 5 y | 5-year | -317.5% | at low | -497.6% | +53.1% | -2830.9% | at low |
| alltime | all time | -317.5% | at low | -497.6% | +53.1% | -2830.9% | at low |
Candel Therapeutics EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$10.16 M(-53.1%) | -$49.83 M(+5.0%) |
| Jun 2024 | - | -$21.67 M(+186.1%) | -$47.43 M(+36.6%) |
| Mar 2024 | - | -$7.58 M(-27.3%) | -$34.73 M(-1.7%) |
| Dec 2023 | -$35.34 M(+106.9%) | -$10.42 M(+34.2%) | -$35.34 M(+20.1%) |
| Sep 2023 | - | -$7.77 M(-13.4%) | -$29.43 M(-1.4%) |
| Jun 2023 | - | -$8.97 M(+9.6%) | -$29.83 M(+21.4%) |
| Mar 2023 | - | -$8.19 M(+81.7%) | -$24.57 M(-3.2%) |
| Dec 2022 | -$17.09 M | -$4.50 M(-44.9%) | -$25.37 M(-10.8%) |
| Sep 2022 | - | -$8.17 M(+120.0%) | -$28.46 M(+1.0%) |
| Jun 2022 | - | -$3.71 M(-58.7%) | -$28.19 M(-3.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$8.99 M(+18.4%) | -$29.17 M(+18.3%) |
| Dec 2021 | -$24.65 M(+86.9%) | -$7.59 M(-3.9%) | -$24.65 M(+7.0%) |
| Sep 2021 | - | -$7.90 M(+68.2%) | -$23.03 M(+29.9%) |
| Jun 2021 | - | -$4.70 M(+5.2%) | -$17.73 M(+14.4%) |
| Mar 2021 | - | -$4.47 M(-25.2%) | -$15.50 M(+21.7%) |
| Dec 2020 | -$13.19 M(+55.8%) | -$5.97 M(+130.2%) | -$12.73 M(+88.4%) |
| Sep 2020 | - | -$2.60 M(+5.4%) | -$6.76 M(+62.3%) |
| Jun 2020 | - | -$2.46 M(+44.9%) | -$4.16 M(+144.9%) |
| Mar 2020 | - | -$1.70 M | -$1.70 M |
| Dec 2019 | -$8.47 M | - | - |
FAQ
- What is Candel Therapeutics annual earnings before interest & taxes?
- What is the all time high annual EBIT for Candel Therapeutics?
- What is Candel Therapeutics annual EBIT year-on-year change?
- What is Candel Therapeutics quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Candel Therapeutics?
- What is Candel Therapeutics quarterly EBIT year-on-year change?
- What is Candel Therapeutics TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Candel Therapeutics?
- What is Candel Therapeutics TTM EBIT year-on-year change?
What is Candel Therapeutics annual earnings before interest & taxes?
The current annual EBIT of CADL is -$35.34 M
What is the all time high annual EBIT for Candel Therapeutics?
Candel Therapeutics all-time high annual earnings before interest & taxes is -$8.47 M
What is Candel Therapeutics annual EBIT year-on-year change?
Over the past year, CADL annual earnings before interest & taxes has changed by -$18.26 M (-106.86%)
What is Candel Therapeutics quarterly earnings before interest & taxes?
The current quarterly EBIT of CADL is -$10.16 M
What is the all time high quarterly EBIT for Candel Therapeutics?
Candel Therapeutics all-time high quarterly earnings before interest & taxes is -$1.70 M
What is Candel Therapeutics quarterly EBIT year-on-year change?
Over the past year, CADL quarterly earnings before interest & taxes has changed by +$11.51 M (+53.12%)
What is Candel Therapeutics TTM earnings before interest & taxes?
The current TTM EBIT of CADL is -$49.83 M
What is the all time high TTM EBIT for Candel Therapeutics?
Candel Therapeutics all-time high TTM earnings before interest & taxes is -$1.70 M
What is Candel Therapeutics TTM EBIT year-on-year change?
Over the past year, CADL TTM earnings before interest & taxes has changed by -$2.39 M (-5.05%)